NCT05920421

Brief Summary

The gold standard for shoulder analgesia is the interscalene block (ISB), but it has its own share of disadvantages such as phrenic nerve block, recurrent laryngeal nerve involvement and Horner's syndrome may lead to patient discomfort .Others, such as intrathecal spread and systemic toxicity of local anesthetic, can have serious consequences. Phrenic nerve injury is a common complication with regional anesthesia. Its either temporary with Transient Phrenic Nerve Palsy leading to hemidiaphragmatic paresis after interscalene block or other injections of local anesthetic in the neck . Although studies of ISB have shown a reduction in the incidence in hemidiaphragmatic paralysis with low-volume ISB, the risk of phrenic paralysis is not completely eliminated. To bypass this complication, distal block of the shoulder innervation is recommended such as subomohyoid infraclavicular and subomohyoid subscapularis blocks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 27, 2023

Completed
23 days until next milestone

Study Start

First participant enrolled

July 20, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

January 2, 2026

Status Verified

December 1, 2025

Enrollment Period

5 months

First QC Date

May 14, 2023

Last Update Submit

December 26, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change is being assessed (Diaphragm excursion)

    As shown before diaphragm excursion will be examined preoperative as basal measurement, immediately postoperative in the PACU and 6 hours postoperatively to detect diaghragm excursion.If ratio of post to pre-block is \< 25% this means that phrenic nerve block is included.

    basal preoperatively , immediately postoperatively in the pacu and 6 hours postoperatively

  • Thickness fraction

    The percentage change in thickness between end expiration and peak inspiration. It was calculated as follows: (thickness at peak inspiration - thickness at end expiration/thickness at end expiration) Ă—100.

    basal preoperatively, immediately postoperatively in the PACU, and 6 hours postoperatively

Secondary Outcomes (3)

  • Visual Analogue Scale (VAS) at different intervals within and between the studied groups

    immediately postoperative in the PACU , 6 hours postoperatively up to 24 hour postoperatively

  • Total pethidine consumption in 24 hours of the studied groups

    24 hours

  • postoperative complication of the studied groups

    24 hours

Study Arms (3)

interscalen group

PLACEBO COMPARATOR

(29) patients will receive an interscalene block before induction of general anaesthesia. Patients will receive 20 ml of bupivacaine 0.25 %+250 mg of magnesium sulphate.

Procedure: diaghragm affection by ultrasound before and after the blocks

subomohyoid infracavicular group

ACTIVE COMPARATOR

(29) patients will receive subomohyoid infraclavicular block before induction of general anesthesia. Patients will receive 20 ml of bupivacaine 0.25 %+250 mg of magnesium sulphate.

Procedure: diaghragm affection by ultrasound before and after the blocks

subomohyoid subscapularis group

ACTIVE COMPARATOR

(29) patients will receive subomohyoid subscapularis block before induction of general anesthesia. Patients will receive 20 mL of 0.25% bupivacaine + 250 mg of magnesium sulfate.

Procedure: diaghragm affection by ultrasound before and after the blocks

Interventions

the participant will assess diaphragm sparing in each block and evaluate effectiveness of infraclavicular subomohyoid blocks and subomohyoid subscapularis blocks according to intraoperative and postoperative analgesia and diaphragm affection and comparing them with interscalen and with each others

interscalen groupsubomohyoid infracavicular groupsubomohyoid subscapularis group

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patient acceptance.
  • ASA I and ASA II.
  • Age 21-60 years old.
  • Both gender.
  • BMI \< 35 Kg/m2.
  • Accepted mental state of the patient.
  • Elective Unilateral upper limb surgeries at the level of the shoulder.
  • Time of surgery less than 2 hours

You may not qualify if:

  • \- Patient refusal.
  • Peripheral neuropathy.
  • Pathological coagulopathy.
  • Infection at the injection site.
  • Untreated pneumothorax.
  • Disturbed conscious level.
  • An allergy to local anesthetics used in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emad Hamdy Mohamed Morsy

Zagazig, Sharqia Province, 44519, Egypt

Location

Related Publications (8)

  • Dhir S, Sondekoppam RV, Sharma R, Ganapathy S, Athwal GS. A Comparison of Combined Suprascapular and Axillary Nerve Blocks to Interscalene Nerve Block for Analgesia in Arthroscopic Shoulder Surgery: An Equivalence Study. Reg Anesth Pain Med. 2016 Sep-Oct;41(5):564-71. doi: 10.1097/AAP.0000000000000436.

    PMID: 27380105BACKGROUND
  • Battaglia PJ, Haun DW, Dooley K, Kettner NW. Sonographic measurement of the normal suprascapular nerve and omohyoid muscle. Man Ther. 2014 Apr;19(2):165-8. doi: 10.1016/j.math.2013.12.005. Epub 2013 Dec 27.

    PMID: 24412231BACKGROUND
  • Musso D, Flohr-Madsen S, Meknas K, Wilsgaard T, Ytrebo LM, Klaastad O. A novel combination of peripheral nerve blocks for arthroscopic shoulder surgery. Acta Anaesthesiol Scand. 2017 Oct;61(9):1192-1202. doi: 10.1111/aas.12948. Epub 2017 Aug 4.

    PMID: 28776638BACKGROUND
  • Bergmann L, Martini S, Kesselmeier M, Armbruster W, Notheisen T, Adamzik M, Eichholz R. Phrenic nerve block caused by interscalene brachial plexus block: breathing effects of different sites of injection. BMC Anesthesiol. 2016 Jul 29;16(1):45. doi: 10.1186/s12871-016-0218-x.

    PMID: 27473162BACKGROUND
  • Panero AJ, Hirahara AM. A Guide to Ultrasound of the Shoulder, Part 2: The Diagnostic Evaluation. Am J Orthop (Belle Mead NJ). 2016 May-Jun;45(4):233-8.

    PMID: 27327915BACKGROUND
  • Boon AJ, O'Gorman C. Ultrasound in the Assessment of Respiration. J Clin Neurophysiol. 2016 Apr;33(2):112-9. doi: 10.1097/WNP.0000000000000240.

    PMID: 27035251BACKGROUND
  • Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003 Sep;4(7):407-14. doi: 10.1016/s1526-5900(03)00716-8.

    PMID: 14622683BACKGROUND
  • Aszmann OC, Dellon AL, Birely BT, McFarland EG. Innervation of the human shoulder joint and its implications for surgery. Clin Orthop Relat Res. 1996 Sep;(330):202-7. doi: 10.1097/00003086-199609000-00027.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer of anethesia and surgical intensive care

Study Record Dates

First Submitted

May 14, 2023

First Posted

June 27, 2023

Study Start

July 20, 2023

Primary Completion

December 20, 2023

Study Completion

December 30, 2024

Last Updated

January 2, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

planned after completion of the study

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
after puplication of the study
Access Criteria
contact of principal investigator

Locations